hydroxyzine has been researched along with Intestinal Diseases in 1 studies
Hydroxyzine: A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.
hydroxyzine : A N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively.
Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pironi, L | 1 |
| Corcos, O | 1 |
| Forbes, A | 1 |
| Holst, M | 1 |
| Joly, F | 1 |
| Jonkers, C | 1 |
| Klek, S | 1 |
| Lal, S | 1 |
| Blaser, AR | 1 |
| Rollins, KE | 1 |
| Sasdelli, AS | 1 |
| Shaffer, J | 1 |
| Van Gossum, A | 1 |
| Wanten, G | 1 |
| Zanfi, C | 1 |
| Lobo, DN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Goal-direct Treatment of Chronic Bowel Dysfunction[NCT04507945] | Phase 1/Phase 2 | 50 participants (Anticipated) | Interventional | 2020-10-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for hydroxyzine and Intestinal Diseases
| Article | Year |
|---|---|
Intestinal failure in adults: Recommendations from the ESPEN expert groups.
Topics: Acute Disease; Adult; Chronic Disease; Europe; Gastrointestinal Tract; Humans; Hydroxyzine; Interdis | 2018 |